Validity and Reliability of ICIQ-FLUTS LF in Thai Version and Correlation With IPSS

NCT ID: NCT06270849

Last Updated: 2024-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-24

Study Completion Date

2024-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators recruited participants, who were female with LUTS 50 participants for known group validity and 80 normal control females to evaluate for construct validity and test for reliability by statistical analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

50 females with LUTS will completed the ICIQ-FLUTS and IPSS and then again at 2 weeks apart to test for convergent validity and test-retest validity.

The normal control group 80 women will completed ICIQ-FLUTS LF for test of construct validity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Validity of Thai Version of the ICIQ-FLUTS LF Questionnaire Reliability of Thai Version of the ICIQ-FLUTS LF

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Female with LUTS

Females who has symptoms of lower urinary tract symptoms

Questionnaire

Intervention Type OTHER

The questionnaire to assess severity of LUTS in women.

Normal control group

Females who no history of LUTS or urinary tract disease

Questionnaire

Intervention Type OTHER

The questionnaire to assess severity of LUTS in women.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

The questionnaire to assess severity of LUTS in women.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age at or over 18 years old
* can read and understand Thai language
* have lower urinary tract symptoms

Exclusion Criteria

* those who have a diagnosis of calculi, urinary tract cancer
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Thammasat University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Valeerat Swatesutipun

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Valeerat Swatesutipun, MD

Role: PRINCIPAL_INVESTIGATOR

Thammasat University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Thammasat University Hospital

Khlong Luang, Changwat Pathum Thani, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MTU-EC-SU-0-002/66

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

LOWER URINARY TRACT SYMPTOMS
NCT06505954 COMPLETED
Tele-rehabilitation for Women With Urinary Incontinence
NCT06161324 ENROLLING_BY_INVITATION NA